Distributor inventory

Treatment of susceptible bacterial infections such as urinary tract infections, respiratory tract infections, skin and soft tissue infections, gastrointestinal infections (including typhoid), and certain genital infections as advised by a doctor

Ofloxacin is a fluoroquinolone antibiotic. It inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and repair, leading to bacterial cell death.

For intravenous infusion only. Administer as a slow IV infusion over the prescribed duration (commonly 30–60 minutes) by a healthcare professional; dose and frequency depend on infection severity and kidney function. Do not give as IV bolus or IM injection; complete the full course as prescribed.

nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, insomnia, injection site pain/redness, rash

Prescription-only antibiotic; use only for proven/suspected bacterial infections. Risk of tendinitis/tendon rupture (higher in elderly, steroid users), peripheral neuropathy, CNS effects (seizures, confusion), QT prolongation/arrhythmias, severe hypersensitivity reactions, photosensitivity, and C. difficile–associated diarrhea. Use with caution in epilepsy/CNS disorders, myasthenia gravis, and in renal impairment (dose adjustment needed). Avoid unnecessary use to prevent resistance.

QT-prolonging drugs (e.g., amiodarone, sotalol, certain antipsychotics/macrolides), warfarin/other anticoagulants (may increase bleeding risk), antidiabetic drugs/insulin (risk of hypo/hyperglycemia), corticosteroids (increased tendon rupture risk), theophylline/NSAIDs (increased seizure risk), probenecid/cimetidine (may increase ofloxacin levels)

Store below 25°C; protect from light; do not freeze. Keep in original container and use immediately after opening as per hospital protocol.

Oflotas IV Infusion 100 ml, Oflox IV Infusion 100 ml, Tarivid IV Infusion 100 ml, Zenflox IV Infusion 100 ml